Figure 1
Stratification of the test cohort (n = 80) for CDKN2A expression identified a subgroup of 8/80 (10.0%) patients with the highest CDKN2A expression who had a much worse RFS (a) and DSS (b) compared to the rest of the cohort.
Figure 1 | Scientific Reports
